Aligos Therapeutics, Inc. · NASDAQ:ALGS

Lawrence M. Blatt reported a 5.60% stake in Aligos Therapeutics, Inc. (Schedule 13D)

Event Jun 16, 2026 · Filed Jun 24, 2026

Lawrence M. Blatt reported a 5.60% stake in Aligos Therapeutics, Inc., 316,228 shares, with active intent on Jun 16, 2026. Filed Jun 24, 2026 (Schedule 13D).

Stake
5.60%
Shares
316,228
Intent
Active
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Lawrence M. Blatt5.60%316,228

Source

View original at SEC

Related